|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.58 USD | -0.33% |
|
-0.74% | +30.45% |
| 05-13 | Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says | MT |
| 05-13 | RBC Lifts Price Target on Legend Biotech to $64 From $62, Keeps Outperform Rating | MT |
| Capitalization | 5.3B 4.53B 4.15B 3.92B 7.26B 507B 7.3B 49.4B 19.23B 241B 19.9B 19.48B 837B | P/E ratio 2026 * |
102x | P/E ratio 2027 * | 24.2x |
|---|---|---|---|---|---|
| Enterprise value | 4.48B 3.82B 3.5B 3.31B 6.13B 429B 6.17B 41.72B 16.24B 203B 16.8B 16.45B 707B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 2.32x |
| Free-Float |
99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Legend Biotech Corporation
| 1 day | -0.30% | ||
| 1 week | -0.74% | ||
| Current month | +20.58% | ||
| 1 month | +51.74% | ||
| 3 months | +56.60% | ||
| 6 months | -6.37% | ||
| Current year | +30.45% |
| 1 week | 24.3 |  | 29.62 |
| 1 month | 18.73 | | 30.41 |
| Current year | 16.24 | | 30.41 |
| 1 year | 16.24 | | 45.3 |
| 3 years | 16.24 | | 77.32 |
| 5 years | 16.24 | | 77.32 |
| 10 years | 16.24 | | 77.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 53 | 20/09/2020 |
Carlos Santos
DFI | Director of Finance/CFO | - | 17/08/2025 |
Simon Wu
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Wang
CHM | Chairman | 57 | 05/11/2020 |
Ying Huang
BRD | Director/Board Member | 53 | 29/12/2021 |
Corazon Sanders
BRD | Director/Board Member | 69 | 30/04/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.33% | -0.74% | +2.01% | -61.23% | 5.3B | |
| -0.06% | +2.38% | +43.98% | +83.11% | 50.04B | |
| -1.28% | -0.07% | +81.96% | +64.48% | 48.62B | |
| -1.64% | +11.05% | +77.72% | +505.09% | 25.57B | |
| -1.24% | -1.47% | -0.47% | -15.06% | 23.32B | |
| -3.60% | -1.92% | +37.14% | -29.43% | 17.89B | |
| -1.66% | -4.83% | +32.60% | -41.30% | 16.2B | |
| -2.75% | -10.22% | +51.16% | +194.76% | 14.97B | |
| -3.81% | +7.46% | -18.99% | +907.10% | 14.58B | |
| -3.89% | -4.44% | +38.83% | - | 13.47B | |
| Average | -2.04% | -2.35% | +34.59% | +178.61% | 23B | |
| Weighted average by Cap. | -1.65% | -2.57% | +45.12% | +159.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.45B 1.24B 1.14B 1.08B 1.99B 139B 2B 13.55B 5.28B 66.07B 5.46B 5.34B 230B | 1.83B 1.56B 1.43B 1.36B 2.51B 175B 2.52B 17.07B 6.65B 83.21B 6.87B 6.73B 289B |
| Net income | 21.16M 18.07M 16.56M 15.65M 28.98M 2.03B 29.13M 197M 76.75M 961M 79.39M 77.73M 3.34B | 310M 265M 243M 230M 425M 29.71B 427M 2.89B 1.13B 14.1B 1.16B 1.14B 49.01B |
| Net Debt | -824M -704M -645M -610M -1.13B -78.87B -1.13B -7.68B -2.99B -37.43B -3.09B -3.03B -130B | -1.05B -900M -824M -779M -1.44B -101B -1.45B -9.82B -3.82B -47.85B -3.95B -3.87B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 28.18 $ | -1.71% | 17,931 |
| 13/05/26 | 28.67 $ | +1.45% | 2,941,515 |
| 12/05/26 | 28.26 $ | +10.48% | 5,050,663 |
| 11/05/26 | 25.58 $ | -9.03% | 3,048,693 |
| 08/05/26 | 28.12 $ | -1.58% | 2,600,698 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LEGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition